tiprankstipranks
Trending News
More News >
Mega Genomics Limited (HK:6667)
:6667
Hong Kong Market
Advertisement

Mega Genomics Limited (6667) Ratios

Compare
0 Followers

Mega Genomics Limited Ratios

HK:6667's free cash flow for Q2 2024 was ¥0.65. For the 2024 fiscal year, HK:6667's free cash flow was decreased by ¥ and operating cash flow was ¥0.38. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
5.43 7.62 9.82 1.36 3.47
Quick Ratio
5.42 7.58 9.77 1.35 3.43
Cash Ratio
3.88 4.92 3.43 0.79 0.99
Solvency Ratio
0.24 -0.03 1.20 0.34 0.16
Operating Cash Flow Ratio
0.48 -0.09 0.44 0.39 0.70
Short-Term Operating Cash Flow Coverage
32.34 0.00 0.00 0.69 3.58
Net Current Asset Value
¥ 541.51M¥ 531.38M¥ 607.67M¥ 80.93M¥ -82.07M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.02 0.01 0.37 0.70
Debt-to-Equity Ratio
0.06 0.02 0.02 0.96 -68.04
Debt-to-Capital Ratio
0.06 0.02 0.02 0.49 1.01
Long-Term Debt-to-Capital Ratio
0.03 0.00 0.00 0.00 -55.29
Financial Leverage Ratio
1.26 1.14 1.11 2.57 -97.61
Debt Service Coverage Ratio
18.22 -2.25 14.44 0.66 2.11
Interest Coverage Ratio
0.00 3.51 15.37 6.68 3.28
Debt to Market Cap
0.01 0.00 0.00 0.04 <0.01
Interest Debt Per Share
0.20 0.06 0.15 0.78 0.85
Net Debt to EBITDA
-11.08 71.73 -1.95 -0.31 1.82
Profitability Margins
Gross Profit Margin
60.76%56.08%70.27%71.96%63.44%
EBIT Margin
27.17%-14.20%43.34%54.84%46.79%
EBITDA Margin
31.59%-3.72%49.19%61.75%58.15%
Operating Profit Margin
16.69%1.73%44.77%54.44%52.00%
Pretax Profit Margin
29.95%-14.70%40.42%46.70%30.96%
Net Profit Margin
25.79%-12.09%33.31%38.92%24.00%
Continuous Operations Profit Margin
25.79%-12.09%33.31%38.92%24.00%
Net Income Per EBT
86.12%82.26%82.41%83.35%77.54%
EBT Per EBIT
179.45%-847.57%90.29%85.79%59.53%
Return on Assets (ROA)
4.14%-2.50%10.23%17.44%11.26%
Return on Equity (ROE)
5.24%-2.85%11.38%44.84%-1098.85%
Return on Capital Employed (ROCE)
3.18%0.40%15.12%57.86%30.53%
Return on Invested Capital (ROIC)
2.64%0.33%12.35%26.40%21.94%
Return on Tangible Assets
4.14%-2.50%10.24%17.46%11.29%
Earnings Yield
2.50%-0.74%4.24%2.18%0.77%
Efficiency Ratios
Receivables Turnover
0.89 0.79 1.16 1.56 1.14
Payables Turnover
1.09 1.84 2.41 2.12 3.77
Inventory Turnover
43.40 18.25 21.47 19.17 18.53
Fixed Asset Turnover
1.52 2.93 4.47 3.25 1.64
Asset Turnover
0.16 0.21 0.31 0.45 0.47
Working Capital Turnover Ratio
0.23 0.25 0.67 1.79 0.00
Cash Conversion Cycle
83.35 284.72 179.22 80.73 241.87
Days of Sales Outstanding
411.16 462.92 313.36 233.91 319.04
Days of Inventory Outstanding
8.41 20.01 17.00 19.04 19.69
Days of Payables Outstanding
336.22 198.21 151.14 172.22 96.87
Operating Cycle
419.57 482.93 330.36 252.95 338.74
Cash Flow Ratios
Operating Cash Flow Per Share
0.30 -0.03 0.24 0.43 0.16
Free Cash Flow Per Share
0.24 -0.06 0.21 0.43 0.15
CapEx Per Share
0.06 0.03 0.03 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.81 1.75 0.86 0.99 0.98
Dividend Paid and CapEx Coverage Ratio
5.17 -1.33 6.93 98.41 48.98
Capital Expenditure Coverage Ratio
5.17 -1.33 6.93 98.41 48.98
Operating Cash Flow Coverage Ratio
1.52 -0.63 2.65 0.61 0.20
Operating Cash Flow to Sales Ratio
0.47 -0.05 0.13 0.51 0.30
Free Cash Flow Yield
3.46%-0.51%1.40%2.81%0.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
40.03 -134.41 23.61 45.80 129.56
Price-to-Sales (P/S) Ratio
11.01 16.25 7.87 17.83 31.10
Price-to-Book (P/B) Ratio
2.08 3.83 2.69 20.54 -1.42K
Price-to-Free Cash Flow (P/FCF) Ratio
28.86 -195.72 71.19 35.59 105.36
Price-to-Operating Cash Flow Ratio
21.83 -342.65 60.91 35.23 103.21
Price-to-Earnings Growth (PEG) Ratio
5.60 1.18 0.27 0.26 0.00
Price-to-Fair Value
2.08 3.83 2.69 20.54 -1.42K
Enterprise Value Multiple
23.77 -365.10 14.04 28.56 55.30
Enterprise Value
1.00B 1.98B 1.64B 3.58B 3.98B
EV to EBITDA
23.77 -365.10 14.04 28.56 55.30
EV to Sales
7.51 13.58 6.91 17.64 32.16
EV to Free Cash Flow
19.68 -163.58 62.51 35.21 108.95
EV to Operating Cash Flow
15.88 -286.38 53.48 34.85 106.73
Tangible Book Value Per Share
3.16 2.99 5.45 0.73 -0.01
Shareholders’ Equity Per Share
3.16 3.00 5.46 0.74 -0.01
Tax and Other Ratios
Effective Tax Rate
0.16 0.18 0.18 0.17 0.22
Revenue Per Share
0.64 0.71 1.86 0.85 0.52
Net Income Per Share
0.16 -0.09 0.62 0.33 0.12
Tax Burden
0.86 0.82 0.82 0.83 0.78
Interest Burden
1.10 1.03 0.93 0.85 0.66
Research & Development to Revenue
0.11 0.13 0.05 0.02 0.04
SG&A to Revenue
0.21 0.29 0.01 <0.01 0.01
Stock-Based Compensation to Revenue
0.02 0.03 0.00 0.00 0.00
Income Quality
1.83 0.32 0.32 1.08 0.97
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis